Inborn errors of human B cell development, differentiation, and function
© 2023 Tangye et al..
B cells develop from hematopoietic stem cells in the bone marrow. Once generated, they serve multiple roles in immune regulation and host defense. However, their most important function is producing antibodies (Ab) that efficiently clear invading pathogens. This is achieved by generating memory B cells that rapidly respond to subsequent Ag exposure, and plasma cells (PCs) that continually secrete Ab. These B cell subsets maintain humoral immunity and host protection against recurrent infections for extended periods of time. Thus, the generation of antigen (Ag)-specific memory cells and PCs underlies long-lived serological immunity, contributing to the success of most vaccines. Our understanding of immunity is often derived from animal models. However, analysis of individuals with monogenic defects that disrupt immune cell function are unprecedented models to link genotypes to clinical phenotypes, establish mechanisms of disease pathogenesis, and elucidate critical pathways for immune cell development and differentiation. Here, we review fundamental breakthroughs in unraveling the complexities of humoral immunity in humans that have come from the discovery of inborn errors disrupting B cell function.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:220 |
---|---|
Enthalten in: |
The Journal of experimental medicine - 220(2023), 7 vom: 03. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tangye, Stuart G [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies |
---|
Anmerkungen: |
Date Completed 07.06.2023 Date Revised 13.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1084/jem.20221105 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357752031 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357752031 | ||
003 | DE-627 | ||
005 | 20231226073253.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1084/jem.20221105 |2 doi | |
028 | 5 | 2 | |a pubmed24n1192.xml |
035 | |a (DE-627)NLM357752031 | ||
035 | |a (NLM)37273190 | ||
035 | |a (PII)e20221105 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tangye, Stuart G |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inborn errors of human B cell development, differentiation, and function |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.06.2023 | ||
500 | |a Date Revised 13.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Tangye et al. | ||
520 | |a B cells develop from hematopoietic stem cells in the bone marrow. Once generated, they serve multiple roles in immune regulation and host defense. However, their most important function is producing antibodies (Ab) that efficiently clear invading pathogens. This is achieved by generating memory B cells that rapidly respond to subsequent Ag exposure, and plasma cells (PCs) that continually secrete Ab. These B cell subsets maintain humoral immunity and host protection against recurrent infections for extended periods of time. Thus, the generation of antigen (Ag)-specific memory cells and PCs underlies long-lived serological immunity, contributing to the success of most vaccines. Our understanding of immunity is often derived from animal models. However, analysis of individuals with monogenic defects that disrupt immune cell function are unprecedented models to link genotypes to clinical phenotypes, establish mechanisms of disease pathogenesis, and elucidate critical pathways for immune cell development and differentiation. Here, we review fundamental breakthroughs in unraveling the complexities of humoral immunity in humans that have come from the discovery of inborn errors disrupting B cell function | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antibodies |2 NLM | |
700 | 1 | |a Nguyen, Tina |e verfasserin |4 aut | |
700 | 1 | |a Deenick, Elissa K |e verfasserin |4 aut | |
700 | 1 | |a Bryant, Vanessa L |e verfasserin |4 aut | |
700 | 1 | |a Ma, Cindy S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of experimental medicine |d 1896 |g 220(2023), 7 vom: 03. Juli |w (DE-627)NLM000005967 |x 1540-9538 |7 nnns |
773 | 1 | 8 | |g volume:220 |g year:2023 |g number:7 |g day:03 |g month:07 |
856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20221105 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 220 |j 2023 |e 7 |b 03 |c 07 |